Evolution of myeloid-mediated immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Kaichun Wu et al.|Nature|2024Cited by 138
TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environmentsYuan-Li Tsai, Arthur Weiss, Marcel Arias-Badia et al.|Immunity|2023Cited by 27
Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4Marcel Arias-Badia, Lawrence Fong, Peixi Chen et al.|JCI Insight|2025Cited by 4
Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Cancer Immunology Research|2025Cited by 0
Abstract 3980: Non-canonical CAR T cell states correlate with durable therapeutic responses in multiple myeloma patientsKai Wu, Lawrence Fong, Karen Law et al.|Cancer Research|2026Cited by 0